Showing results (531-540 of 540) with videos related to

Sort By:
Pageof 54
You have reached the last page of results.This site can display upto 540 results.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 7, 2006
Expression of cyclooxygenase-2 in epithelial ovarian tumors and its relation to vascular endothelial growth factor and p53 expressionJ S Lee, Y D Choi, J H Lee, et al.
The Journal of Heart Transplantation|March 1, 1987
Bridging circulatory support before heart transplant without invasion of the mediastinumS J Phillips, R H Zeff, W J Wickemeyer, et al.
Diabetes, Obesity & Metabolism|January 17, 2013
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor gemigliptin compared with sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin aloneE J Rhee, W Y Lee, K W Min, et al.
Breast (Edinburgh, Scotland)|September 20, 2005
Expression of cyclooxygenase-2 in breast carcinogenesis and its relation to HER-2/neu and p53 protein expression in invasive ductal carcinomaM H Cho, J H Yoon, Y J Jaegal, et al.
Diabetes, Obesity & Metabolism|January 13, 2015
Lobeglitazone and pioglitazone as add-ons to metformin for patients with type 2 diabetes: a 24-week, multicentre, randomized, double-blind, parallel-group, active-controlled, phase III clinical trial with a 28-week extensionS-M Jin, C-Y Park, Y M Cho, et al.
Diabetes, Obesity & Metabolism|December 20, 2014
Anagliptin and sitagliptin as add-ons to metformin for patients with type 2 diabetes: a 24-week, multicentre, randomized, double-blind, active-controlled, phase III clinical trial with a 28-week extensionS-M Jin, S W Park, K-H Yoon, et al.
Diabetes, Obesity & Metabolism|November 23, 2012
A multicentre, multinational, randomized, placebo-controlled, double-blind, phase 3 trial to evaluate the efficacy and safety of gemigliptin (LC15-0444) in patients with type 2 diabetesS J Yang, K W Min, S K Gupta, et al.
International Journal of Clinical Practice|January 23, 2013
Efficacy and safety of glimepiride/metformin sustained release once daily vs. glimepiride/metformin twice daily in patients with type 2 diabetesY-C Hwang, M Kang, C W Ahn, et al.
Diabetes, Obesity & Metabolism|October 28, 2010
A multicenter, randomized, placebo-controlled, double-blind phase II trial evaluating the optimal dose, efficacy and safety of LC 15-0444 in patients with type 2 diabetesE J Rhee, W Y Lee, K H Yoon, et al.
Optics Express|February 8, 2013
Slewing Mirror Telescope optics for the early observation of UV/optical photons from Gamma-Ray BurstsS Jeong, J W Nam, K B Ahn, et al.
Pageof 54